the transaction size. And the beauty of that is it will give us flexibility to have a smaller starting base of capital, but effectively an unlimited amount of capital to pursue even a very large acquisition and to kind of tailor -make the capital for the situation. And that makes actually the warrants more valuable and makes the entity more likely to find a transaction that makes sense, because rather than having a fixed base of capital with a floating basic capital plus backing from us as the sponsor, we believe that entity will be the best entity in the world in which to come public. Other interesting attributes, no underwriting fees; in a typical SPAC, there is 5.5% leakage in underwriting fees.
We are going to give the publicly distributable warrant holders two SPARC warrants for each distributable warrant that they hold, so the ultimate capital structure will be 200 million warrants with a strike price of $10 with our ability to upsize that strike price to really any number, plus another 44 million, two for each of the 22 million distributable warrants that are outstanding, which means that 244 million warrants will become stock if and when we identify a transaction that makes sense and people exercise. Just so you understand the math, at $10 that means we’d raise $2.4 billion from the public; at $20 we’d raise $4.8 billion from the public, assuming everyone exercises their warrants. And if the transaction requires a $10 billion equity check or a $15 billion equity check, what’s fascinating is as long as the transaction makes sense and the warrants have positive value, they will very likely get exercised, and that means we have total flexibility to pursue transactions of really any size. So no underwriting fees, no upfront cost, no opportunity cost of capital, the ability to tailor -make the transaction size, and we think this will make for a very, very interesting entity.
There also won’t be any shareholder warrants outstanding, so it will be a pure common stock capital structure, which will make the potential upside for a shareholder greater because there’s no shareholder warrant dilution, and our sponsor director warrants will be approximately 5% of the entity, versus 6% for the existing PSTH. We’ve designed it to be a super -efficient structure and we’re excited about it and you’ll read more about it in our upcoming prospectus filing.
But let’s just briefly address the litigation and Halit, why don’t you just summarize where things stand?
[Halit Coussin, Chief Legal Officer/Chief Compliance Officer of PSCM, speaking]
We recently filed a brief in support of our motion to dismiss, that was on November 4. I actually encourage everyone to read that brief. We explain there a variety of reasons why we think this case should be dismissed. The plaintiff has until Monday, November 29, to file their opposition to our motion, and then we will have another two weeks to file our response. And by that point the motion will be fully briefed. Judge Torres will then most likely schedule a hearing to consider our motion and then will make a decision. In the meantime there’s also a process that commenced for discovery. This is in front of a magistrate judge and that just started and will be ongoing.
[William Ackman speaking]
-2-